251 related articles for article (PubMed ID: 9022761)
41. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
[TBL] [Abstract][Full Text] [Related]
42. Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI.
Benedetti B; Charil A; Rovaris M; Judica E; Valsasina P; Sormani MP; Filippi M
Neurology; 2006 Feb; 66(4):535-9. PubMed ID: 16505308
[TBL] [Abstract][Full Text] [Related]
43. Detection and staging of chondromalacia patellae: relative efficacies of conventional MR imaging, MR arthrography, and CT arthrography.
Gagliardi JA; Chung EM; Chandnani VP; Kesling KL; Christensen KP; Null RN; Radvany MG; Hansen MF
AJR Am J Roentgenol; 1994 Sep; 163(3):629-36. PubMed ID: 8079858
[TBL] [Abstract][Full Text] [Related]
44. Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging.
Melhem ER; Breiter SN; Ulug AM; Raymond GV; Moser HW
AJR Am J Roentgenol; 1996 Mar; 166(3):689-95. PubMed ID: 8623652
[TBL] [Abstract][Full Text] [Related]
45. [Adrenal myelolipomas: their magnetic resonance assessment].
Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Di Vito A; Perri G
Clin Ter; 1996 Nov; 147(11):549-57. PubMed ID: 9264908
[TBL] [Abstract][Full Text] [Related]
46. Contrast-enhanced magnetization transfer imaging: improvement of brain tumor conspicuity and delineation for radiosurgical target volume definition.
Hawighorst H; Debus J; Schreiber W; Knopp MV; Engenhart-Cabillic R; Essig M; Brix G; van Kaick G
Radiother Oncol; 1997 Jun; 43(3):261-7. PubMed ID: 9215785
[TBL] [Abstract][Full Text] [Related]
47. Subependymal Giant Cell Astrocytoma Size Measurement in Tuberous Sclerosis Complex: Noncontrast vs Contrast-Enhanced 3-Dimensional T1-Weighted Magnetic Resonance Imaging (MRI).
Hill BJ; Gadde JA; Palasis S
J Child Neurol; 2019 Dec; 34(14):922-927. PubMed ID: 31424303
[TBL] [Abstract][Full Text] [Related]
48. [Study of spondylodiscitis with magnetic resonance. Use of gadolinium-DTPA].
Duca S; Lo Bello G; Bianchi G; Di Paola A
Radiol Med; 1993 Nov; 86(5):587-94. PubMed ID: 8272542
[TBL] [Abstract][Full Text] [Related]
49. Synergistic enhancement of MRI with Gd-DTPA and magnetization transfer.
Tanttu JI; Sepponen RE; Lipton MJ; Kuusela T
J Comput Assist Tomogr; 1992; 16(1):19-24. PubMed ID: 1729300
[TBL] [Abstract][Full Text] [Related]
50. [Gadolinium-DTPA combined with a fat suppression technique in studies with magnetic resonance at 0.5 T in soft-tissue neoplasms].
Battolla L; Zampa V; Mascalchi M; Falaschi F; Bagnolesi P; Tessa C; Paolicchi A; Bartolozzi C
Radiol Med; 1994 Oct; 88(4):353-8. PubMed ID: 7997603
[TBL] [Abstract][Full Text] [Related]
51. In vivo regional cerebral blood volume: quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging.
Kuppusamy K; Lin W; Cizek GR; Haacke EM
Radiology; 1996 Oct; 201(1):106-12. PubMed ID: 8816529
[TBL] [Abstract][Full Text] [Related]
52. Measurement of magnetization transfer in different stages of neurocysticercosis.
Kathuria MK; Gupta RK; Roy R; Gaur V; Husain N; Pradhan S
J Magn Reson Imaging; 1998; 8(2):473-9. PubMed ID: 9562078
[TBL] [Abstract][Full Text] [Related]
53. [The contribution of gadolinium to the magnetic resonance diagnosis of spondylodiscitis].
Dalla Palma L; Pozzi-Mucelli R; Cova M; Iannis MR; Pagnan L
Radiol Med; 1991 Oct; 82(4):393-400. PubMed ID: 1767043
[TBL] [Abstract][Full Text] [Related]
54. Spin-lattice relaxation and magnetization transfer in intracranial tumors in vivo: effects of Gd-DTPA on relaxation parameters.
Kurki T; Komu M
Magn Reson Imaging; 1995; 13(3):379-85. PubMed ID: 7791547
[TBL] [Abstract][Full Text] [Related]
55. Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis.
Rovaris M; Bozzali M; Rodegher M; Tortorella C; Comi G; Filippi M
J Neurol Sci; 1999 Jun; 166(1):58-63. PubMed ID: 10465501
[TBL] [Abstract][Full Text] [Related]
56. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study.
Filippi M; Inglese M; Rovaris M; Sormani MP; Horsfield P; Iannucci PG; Colombo B; Comi G
Neurology; 2000 Oct; 55(7):940-6. PubMed ID: 11061248
[TBL] [Abstract][Full Text] [Related]
57. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements.
Loevner LA; Grossman RI; Cohen JA; Lexa FJ; Kessler D; Kolson DL
Radiology; 1995 Aug; 196(2):511-5. PubMed ID: 7617869
[TBL] [Abstract][Full Text] [Related]
58. Improving acute demyelinating lesion detection: which T1-weighted magnetic resonance acquisition is more sensitive to gadolinium enhancement?
Amaral LLFD; Fragoso DC; Rocha AJD
Arq Neuropsiquiatr; 2019 Jul; 77(7):485-492. PubMed ID: 31365640
[TBL] [Abstract][Full Text] [Related]
59. The role of magnetic resonance imaging in children with intraocular tumors and simulating lesions.
Potter PD; Shields CL; Shields JA; Flanders AE
Ophthalmology; 1996 Nov; 103(11):1774-83. PubMed ID: 8942869
[TBL] [Abstract][Full Text] [Related]
60. Improved visualization of breast lesions with gadolinium-enhanced magnetization transfer MR imaging.
Schreiber WG; Brix G; Knopp MV; Hess T; Lorenz WJ
Magn Reson Med; 1996 Jun; 35(6):861-9. PubMed ID: 8744014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
